Gastroenterology Billing Specialists
Screening vs. diagnostic colonoscopy. Polyp removal technique codes. ERCP component stacking. ASC facility fees. GI billing has more code-selection rules than almost any procedural specialty — Healix captures every billable component, every time.
Why Gastroenterology Billing Loses More Revenue Per Procedure Than Almost Any Other Specialty
GI procedures are among the highest-reimbursed in outpatient medicine — but each one carries multiple code-selection decisions that directly determine how much the practice collects. The screening vs. diagnostic distinction, polyp removal technique, ERCP component count, pathology specimen tally — getting each right requires specialty-specific expertise on every single claim.
The average GI practice without specialty billing support collects only 63–72% of its legitimate procedure revenue. The gap is largest in ERCP (missing components), colonoscopy polypectomy (wrong technique code), and pathology (per-procedure instead of per-specimen billing).
- We assign screening vs. diagnostic codes before the procedure — preventing the #1 GI denial.
- We document polyp removal technique per polyp — capturing the correct code every time.
- We bill every ERCP component — averaging $3,190 vs. the industry's $1,850.
- We bill pathology per specimen jar — not per procedure.
- We optimize ASC facility fees — adding an average 32% to facility revenue.
Six GI Billing Complexity Factors That Cause the Biggest Revenue Gaps
1Screening vs. Diagnostic Colonoscopy — the Most Costly GI Distinction
Medicare covers screening colonoscopy under G0121 (average risk) or G0105 (high risk) with no patient cost-sharing. If a polyp is found and removed during a screening colonoscopy, the code converts to a diagnostic code (45378/45380/45385) and modifier -PT (or -33) is appended to preserve the screening cost-sharing waiver. Failing to append modifier -PT after polypectomy means the patient is billed a full procedure cost-share, triggers complaints and audits. Forgetting to convert the code at all means payers deny the therapeutic component entirely.
2Polyp Removal Technique Determines the Code — and Revenue
Cold forceps biopsy (45380), hot biopsy forceps (45384), cold snare polypectomy (45385), and endoscopic mucosal resection (45390) are not interchangeable — each corresponds to a specific removal technique that must be explicitly documented in the procedure note. Code selection based on the wrong technique costs $80–$250 per polyp. When multiple polyps are removed using different techniques in the same session, the highest-valued technique is primary and others add as separate codes. Most practices bill 45380 for all polyps regardless of technique.
3ERCP Multi-Component Code Stacking
ERCP generates 3–6 separately billable CPT codes in a single procedure — diagnostic ERCP (43260), sphincterotomy (43262), stone removal (43264), dilation (43263), stent placement (43274). Each requires explicit procedural documentation of what was attempted, what succeeded, and fluoroscopy time. Practices that bill a single ERCP code for a multi-component procedure receive $1,850 instead of the $3,100–$4,200 that a fully documented ERCP generates. Healix's ERCP documentation checklist is deployed at each advance endoscopy suite.
4ASC vs. Hospital Outpatient Facility Fee Distinction
GI procedures performed in an Ambulatory Surgery Center use the ASC fee schedule — a different (often lower) base than hospital outpatient, but with different rules for ancillary service billing and device pass-through payments. Professional fees (physician) must be billed separately from facility fees (ASC), using modifier -26 on the professional claim and distinct revenue codes on the facility claim. Practices that own their ASC and fail to optimize the facility billing component leave 15–25% of facility revenue uncaptured.
5Anesthesia Billing Coordination — CRNA vs. Anesthesiologist
GI suite anesthesia (propofol sedation, monitored anesthesia care) creates a three-way billing complexity: the gastroenterologist bills the procedure, the anesthesia provider bills separately (if attending anesthesiologist or CRNA), and the facility bills the room/supply fees. When the gastroenterologist also administers sedation (increasingly rare), they may bill 99152/99153. Coordination failures cause duplicate billing, missing anesthesia claims, or the gastroenterologist billing sedation when an anesthesia provider has already submitted.
6Capsule Endoscopy and Motility Study Prior Authorization
Capsule endoscopy (91110) and Bravo pH monitoring (91035) carry high authorization requirements — most commercial payers require documentation of failed conventional endoscopy, failed empiric treatment, or specific diagnostic criteria before approving these studies. Without prior authorization, denials are automatic and appeals rarely succeed retroactively. Healix pre-authorizes all capsule and motility studies and maintains payer-specific criteria libraries for expedited approval.
GI Procedure Codes With the Highest Billing Error Rates — and Why
Each row below represents a systematic revenue error that Healix's GI-trained billers prevent on every claim.
| CPT Code | Description | Common Billing Error |
|---|---|---|
| G0121 | Screening colonoscopy, average risk (Medicare) — no patient cost-share | Used for high-risk patients (should be G0105) — causes denials and compliance exposure |
| 45385 | Colonoscopy with snare polypectomy — highest-reimbursed polyp removal | Downgraded to 45380 (biopsy) when snare removal is documented — $80–250 lost per polyp |
| 45390 | Colonoscopy with endoscopic mucosal resection (EMR) | Billed as 45385 (snare) — EMR reimburses significantly higher and requires specific documentation |
| 43262 | ERCP with sphincterotomy/papillotomy | Not billed as add-on to 43260 (diagnostic ERCP) — one of the most commonly missed ERCP components |
| 43264 | ERCP with stone extraction from bile duct | Bundled under 43262 — but stone removal is a separately billable add-on per AMA CPT |
| 91110 | Capsule endoscopy of the small bowel with image reading and interpretation | No prior authorization obtained — automatic denial from all commercial payers |
| 88305 | Level IV surgical pathology — GI biopsy, each separate specimen jar | Billed once per procedure instead of per specimen — loses $80+ per additional specimen |
| 46221 | Hemorrhoid banding by rubber band ligation, single hemorrhoid column | One unit billed when 2–3 columns treated — each column is separately billable per CPT |
Why Gastroenterology Claims Are Denied — and Our Exact Resolution
These five denial patterns account for 90%+ of all GI claim denials across our client practices.
Screening Colonoscopy Billed as Diagnostic (or Vice Versa)
This is the #1 GI denial — screening colonoscopy codes (G0121/G0105) are denied when the patient had symptoms that should have triggered a diagnostic code (45378), and diagnostic codes are denied when the referral indication was preventive screening without symptoms. Incorrect code-to-indication matching also affects patient cost-sharing, creating compliance liability. Healix implements a pre-procedure code assignment workflow triggered by the referral indication in the scheduling note.
Modifier -PT Missing After Polypectomy During Screening
When a screening colonoscopy converts to therapeutic after polyp removal, modifier -PT (for Medicare) or -33 (for commercial) must be added to preserve the patient's cost-sharing waiver. Missing this modifier causes the payer to apply a deductible/copay retroactively — which then creates patient billing disputes and audit flags. Healix's claim system automatically detects screening-to-therapeutic conversions and appends the appropriate modifier.
ERCP Components Denied as Bundled Under Primary Code
Payers frequently attempt to bundle 43262 (sphincterotomy) and 43264 (stone removal) under the primary 43260 ERCP code. This is incorrect — CPT guidelines explicitly allow separate billing for each therapeutic component. Healix defeats these improper bundling denials with modifier -59 documentation and AMA CPT guideline appeals, recovering an average of $1,250+ per appeal.
Duplicate Claim — ASC Facility and Professional Fee Both Submitted as Global
When a gastroenterologist's billing team submits the professional fee without modifier -26, and the ASC submits the facility fee, the payer sees a global claim (professional + technical combined) from one entity and the facility claim from another — triggering a duplicate payment flag and denying the facility claim. Healix maps every physician's practice setting at onboarding to prevent global/professional fee conflicts.
Pathology Billed Per Procedure Instead of Per Specimen
GI pathology (CPT 88305) is billed per specimen jar — not per procedure. A colonoscopy that generates 3 separate biopsy jars (cecum, transverse colon, rectum) bills 88305 × 3. Practices that submit a single 88305 per procedure lose $80–$90 per additional specimen. Healix coordinates with pathology to confirm specimen count before final claim submission.
Three Revenue Opportunities Most GI Practices Leave Behind Every Month
Capsule endoscopy utilization, motility testing, and ASC facility optimization are available in virtually every GI practice — but rarely fully captured.
Capsule Endoscopy Suite
CPT 91110 (small bowel) / 91111 (esophageal) / 91113 (colon)
Capsule endoscopy is one of the highest-reimbursed non-invasive GI procedures after colonoscopy. Small bowel CE (91110) reimburses approximately $950; colon capsule endoscopy (91113) reimburses $1,350–$1,400 when authorized. The key barrier is prior authorization — most practices have low capsule utilization because they lack the authorization workflow. Healix's GI auth team manages capsule PA with payer-specific clinical criteria, achieving 89% first-attempt approval.
Bravo pH & GI Motility Testing
CPT 91035 (Bravo pH) / 91010 (esophageal manometry) / 91117 (colonic transit)
Bravo pH monitoring (91035) — a 48–96 hour ambulatory pH study — generates a procedure fee plus a separate data download and interpretation fee billed under 91037/91038. Esophageal high-resolution manometry (91010) reimburses approximately $480. These diagnostic studies are underutilized in most GI practices because of unclear coding and authorization complexity. Healix builds the billing workflow for each study type at onboarding.
ASC Facility Fee Optimization
Facility Revenue Codes — Device Pass-Throughs, Supply Fees, Ancillary Services
GI ASCs frequently under-bill their facility component by missing device pass-through payments (for expensive single-use staplers, hemostasis devices, and stent systems), failing to bill separately for high-cost drugs (propofol, glucagon), and not capturing all supply revenue codes. Healix conducts a full ASC facility fee audit within the first 30 days, identifying all missing revenue codes. The average GI ASC sees a 32% increase in facility revenue without changing procedure volume.
Our Gastroenterology Billing Process
A procedure-centric workflow that starts before the scope is inserted and ends with ERCP component appeals — eliminating the most common GI revenue leaks at every stage.
Pre-Procedure Code Assignment
At scheduling, we analyze the referral indication, patient history, and procedure plan to assign preliminary CPT codes. Screening vs. diagnostic is determined before the patient arrives — preventing the #1 GI denial before the scope is even inserted.
Intraoperative Documentation Support
For ERCP and complex colonoscopies, we deploy procedure-specific documentation checklists to your GI suite. Polyp size, location, and removal technique are captured per-polyp. ERCP components are documented as they occur — not reconstructed from memory post-procedure.
Pathology Specimen Reconciliation
We cross-reference the procedure note with the pathology accessioning report to confirm specimen count. 88305 is billed per jar. If the pathology report shows 4 specimens and only 1 was billed, we correct and rebill before the ARs age.
Claim Scrubbing — GI NCCI Edits
Every GI claim is scrubbed against current NCCI bundling edits, screening-vs-diagnostic modifier rules, and payer-specific GI LCDs. Modifier -PT, -59, and -26 are automatically applied where rules require them. Our 97.8% first-pass rate reflects this pre-submission rigor.
ERCP & Bundling Denial Appeals
When payers improperly bundle ERCP components or deny justified therapeutic add-ons, we appeal within 48 hours using AMA CPT guidelines, operative documentation, and payer-specific LCD citations. Our ERCP component appeal success rate exceeds 91%.
Gastroenterology Results We Deliver
Tracked outcomes from GI practices and endoscopy centers in their first 90 days with Healix RCM.
GI-specific EHR and endoscopy documentation systems we integrate with natively
Gastroenterology Billing FAQs
In-depth answers to the billing questions GI practices and endoscopy center administrators ask us most.
QWhat is the difference between a screening and diagnostic colonoscopy for billing?
A screening colonoscopy is performed on an asymptomatic patient for cancer prevention or early detection. For Medicare patients, average-risk screening uses code G0121; high-risk screening (family history, prior polyps) uses G0105. These codes have no patient cost-sharing. A diagnostic colonoscopy (CPT 45378) is performed because the patient has symptoms — rectal bleeding, changed bowel habits, anemia — or because a previous abnormal test warrants evaluation. If a patient is scheduled as screening but arrives with symptoms documented in the chart, some payers will convert the claim to diagnostic during audit. Healix reviews the referral indication and patient history at scheduling to assign the correct code before the procedure occurs.
QWhat happens to the billing code when a polyp is found during a screening colonoscopy?
When a polyp is found and removed during a screening colonoscopy, the primary code changes from the screening code (G0121) to the therapeutic procedure code (e.g., 45385 for snare polypectomy). Medicare requires modifier -PT to be appended to the new code to preserve the patient's cost-sharing waiver — without -PT, the patient owes a copay/deductible even though the original procedure was preventive. Commercial payers may use modifier -33 instead. Healix's claim system detects screening-to-therapeutic conversions automatically and appends the correct modifier based on the patient's insurance plan.
QWhy does the polyp removal technique matter so much for billing?
CPT codes for polyp removal are technique-specific: cold forceps biopsy (45380, ~$720), hot biopsy forceps (45384, ~$760), cold snare polypectomy (45385, ~$880), endoscopic mucosal resection (45390, ~$1,100). Each requires explicit documentation of the technique used in the procedure note. When a physician performs a cold snare polypectomy and the note says 'biopsy,' the default billing code is 45380 — losing approximately $160 per polyp. Across a busy GI practice performing 200+ colonoscopies per month with polyp removal, systematic technique undercoding can cost $32,000+ per month. Healix uses polyp-level documentation templates with technique checklists.
QCan we bill for multiple ERCP components separately — or is everything bundled under the base ERCP code?
Multiple ERCP components are separately billable. The base diagnostic ERCP code (43260) covers imaging of the biliary and/or pancreatic ducts. Therapeutic interventions are add-on codes: sphincterotomy (43262), lithotripsy (43265), stone extraction (43264), balloon dilation (43263), stent placement (43274), stent removal (43275). Each must be documented separately with specific procedural detail. When payers attempt to bundle these components under 43260, citing NCCI edits, the correct response is an appeal with modifier -59 applied to each add-on and documentation citing the ERCP CPT codebook's definition of separately reportable services. Healix's advance endoscopy billing team manages this code stack for every ERCP encounter.
QHow should we bill when our gastroenterologists perform procedures at their own ASC?
When a physician performs a procedure at a facility they own, two separate claims must be submitted: the professional fee claim (from the physician/group NPI), and the facility fee claim (from the ASC NPI and Tax ID). The professional claim does NOT include modifier -26 in a physician-owned ASC — the physician may bill the global code if they own both the professional and facility components. However, the facility claim must use the ASC fee schedule revenue codes separately from the professional claim. Healix establishes the correct billing entity structure at onboarding, ensuring both claims are submitted correctly, optimizing both professional and facility revenue simultaneously.
QHow do we bill pathology for multiple GI biopsies in one session?
CPT 88305 (Level IV Surgical Pathology) is billed per specimen submitted for pathology review — not per procedure, and not per block or slide. If a colonoscopy generates biopsies placed in 4 separate specimen jars (e.g., cecum, ascending colon, transverse colon, and sigmoid colon), you bill 88305 × 4. Each jar represents a separately accessioned specimen. The pathology report will list each specimen separately by number. Practices that bill 88305 × 1 for every procedure, regardless of specimen count, are systematically losing $80–$90 per additional specimen. Healix reconciles the procedure note specimen count against the pathology accessioning report before submitting any pathology claim.
QWhat prior authorization is typically needed for capsule endoscopy?
Capsule endoscopy (91110 for small bowel) requires prior authorization from virtually all commercial payers and Medicare Advantage plans. Requirements vary by payer but typically include: (1) documentation of suspected small bowel bleeding or obscure gastrointestinal bleeding after upper and lower endoscopy have been normal; or (2) suspected Crohn's disease with negative conventional endoscopy; or (3) suspected small bowel tumor. Some payers require a failed empiric iron infusion trial for occult bleeding cases. Healix maintains a payer-specific clinical criteria library for capsule endoscopy, allowing our authorization team to prepare complete, criteria-specific auth requests — achieving 89% first-attempt approval vs. the industry average of 60%.
QHow do you handle the Bravo pH monitoring billing — is there a separate reading fee?
Bravo pH monitoring is billed in two parts: the placement of the pH capsule (91035 — includes the 48-hour monitoring initiation) and the data download and interpretation (91037 for the recording period, 91038 for each additional hour of monitoring beyond the initial). If the physician places the capsule in-office and downloads/interprets the data after the monitoring period, both the placement code and the interpretation code are billable. If the patient wears the capsule for 96 hours (the extended Bravo protocol), additional recording time codes apply. Medicare's reimbursement for 91035 is approximately $480 for placement; 91037/91038 add $120–$180 for interpretation. Healix builds the two-claim Bravo protocol at onboarding, ensuring both components are always captured.
Ready to Capture Full GI Procedure Revenue?
Get a free audit of your colonoscopy coding accuracy, ERCP component capture, pathology billing, and ASC facility revenue. We'll identify exactly what your practice is missing — with no obligation to sign.